CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines
Companies like GPI, BWA and AN increase their buyback authorization to investors' delight.
Chevron Corporation (NYSE:CVX, ETR:CHV)'s US$53 billion takeover of Hess Corp (NYSE:HES) should be stopped over fears gas prices could be hiked, senator Chuck Shumer has urged. Schumer, who serves as senate majority leader, took to social media X to dispute the merger, which would see Chevron gain a larger footprint in the US and a stake in the Guyana discoveries held by rival Exxon Mobil.
Venu Krishna, Barclays head of US equity strategy, joins CNBC's 'Squawk on the Street' to discuss markets, inflation, the Fed, earnings, and more.
CHARLOTTE, N.C. , May 13, 2024 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced plans to host conference calls to review 2025 quarterly financial results on the following dates and times: First quarter 2025 – Thursday, April 17, 2025, at 8 a.m.
Walgreens Boots Alliance is contacting potential buyers considering a potential sale of its UK-based Boots drugstore chain in a second attempt at separating the unit, Bloomberg News reported on Monday, sending shares up 7%.
Former marketer at insurance firm credited with sparking 2021 meme stock rally returned to X after three years off social media
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) shares are up 6.6% on a report that the US group is talking to potential buyers of its Boots arm. Advisers have been hired and potential buyers are being sounded out over the £7 billion UK chemist chain, according to a Bloomberg report.
The mean of analysts' price targets for Veracyte (VCYT) points to a 39.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The mean of analysts' price targets for ClearPoint Neuro (CLPT) points to a 70.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The mean of analysts' price targets for SolarWinds (SWI) points to a 34.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.